Tumor Suppressor Genes - The Cellular Brakes
Function as cellular "brakes" to halt uncontrolled cell proliferation. Require a "two-hit" loss of function to trigger malignancy (Knudson's hypothesis).
- p53 ("Guardian of the Genome"): Monitors DNA damage; initiates apoptosis. Mutated in >50% of human cancers.
- Rb (Retinoblastoma): Controls the G1/S checkpoint.
⭐ Li-Fraumeni syndrome results from a germline p53 mutation, predisposing individuals to various cancers at a young age.

p53 - Guardian's Gambit
- Function: "Guardian of the Genome"; activated by hypoxia, DNA damage, or oncogene expression.
- Mechanism: Halts cell cycle at G1/S checkpoint via p21 induction to allow for DNA repair. If repair fails, it triggers apoptosis by upregulating BAX.
- Regulation: Tightly controlled by MDM2, a ubiquitin ligase that promotes p53 degradation.
⭐ Inactivation of p53 allows cells with damaged DNA to proliferate, a hallmark of most human cancers. Li-Fraumeni syndrome results from a germline mutation in one p53 allele.

Rb & Friends - The Cycle Sentinels
- Rb (Retinoblastoma protein): The "Governor" of the cell cycle; master regulator of the G1 → S checkpoint.
- Active (hypophosphorylated): Binds and inhibits E2F transcription factor, halting the cell cycle.
- Inactive (hyperphosphorylated): Releases E2F, allowing progression to S phase.
- Regulation Pathway:
- Growth factors → ↑ Cyclin D/CDK4 → Hyperphosphorylates Rb.
- p16 (a CDK inhibitor) blocks the Cyclin/CDK complex, keeping Rb active.
- Knudson's Two-Hit Hypothesis:
- Hereditary: Germline mutation (1st hit) + somatic (2nd hit) → Bilateral retinoblastoma, osteosarcoma.
- Sporadic: Two somatic hits → Unilateral retinoblastoma.
⭐ Patients with familial retinoblastoma (one germline Rb mutation) have a greatly increased risk of developing osteosarcoma later in life.
More Suppressors - The Watchful Guardians
| Gene | Function / Pathway | Key Associated Syndromes & Cancers |
|---|---|---|
| APC | Negative regulator of β-catenin/WNT pathway. | FAP (Familial Adenomatous Polyposis) → near 100% risk of colon cancer. 📌 Adenomatous Polyposis Coli. |
| BRCA1/BRCA2 | DNA repair via homologous recombination. | Hereditary Breast & Ovarian Cancer (HBOC). ↑ risk for prostate & pancreatic cancer. BRCA1 often linked to triple-negative breast cancer. |
| WT1 | Transcription factor for renal & gonadal differentiation. | Wilms Tumor (nephroblastoma). Part of WAGR Syndrome (Wilms, Aniridia, Genitourinary anomalies, Retardation). |
| VHL | Ubiquitin ligase for HIF-1α (hypoxia-inducible factor). | von Hippel-Lindau disease. ↑ risk for clear cell Renal Cell Carcinoma, pheochromocytoma, hemangioblastomas. |
- Tumor suppressor genes are the "brakes" of cell growth, requiring a "two-hit" loss of function (Knudson hypothesis).
- p53, the "guardian of the genome," is the most frequently mutated gene, halting proliferation of DNA-damaged cells.
- Rb controls the G1/S checkpoint; inactivation is linked to retinoblastoma and osteosarcoma.
- Inherited germline mutations (first hit) in APC or BRCA1/2 predispose to hereditary cancer syndromes.
- Loss of heterozygosity (LOH) is the classic mechanism for the required second hit.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app